A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma.
Bartlett NL, Herrera AF, Domingo-Domenech E, Mehta A, Forero-Torres A, Garcia-Sanz R, Armand P, Devata S, Izquierdo AR, Lossos IS, Reeder C, Sher T, Chen R, Schwarz SE, Alland L, Strassz A, Prier K, Choe-Juliak C, Ansell SM.
Bartlett NL, et al. Among authors: devata s.
Blood. 2020 Nov 19;136(21):2401-2409. doi: 10.1182/blood.2019004701.
Blood. 2020.
PMID: 32730586
Free PMC article.
Clinical Trial.